TC
CME icon

Trilogy Capital’s CME Group CME Stock Holding History

Trilogy Capital’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-44
Closed -$7K – 207
2018
Q3 		$7K Hold
44
– – ﹤0.01% 352
2018
Q2 		$7K Hold
44
– – ﹤0.01% 332
2018
Q1 		$7K Sell
44
-4,545
-99% -$724K ﹤0.01% 285
2017
Q4 		$670K Buy
+4,589
New +$654K 0.11% 57

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Trilogy Capital's CME Position: Q4 2018 in Review

Trilogy Capital sold out of CME Group (CME) in Q4 2018, closing a stake of 44 shares — an estimated $7K sold.

Trilogy Capital first reported a position in CME in Q4 2017 and held it in 4 quarters. The position peaked at $670K in Q4 2017. 1,014 funds tracked by Wall St. Rank hold CME as of Q4 2018.

  • Trilogy Capital reported no remaining CME Group position as of Q4 2018 after selling out during the quarter.
  • Trilogy Capital sold 44 CME Group shares in Q4 2018, an estimated $7K.
  • Trilogy Capital first reported a position in CME Group in Q4 2017 and held it in 4 quarters.
  • Trilogy Capital's CME Group position peaked at $670K in Q4 2017.
  • 1,014 funds tracked by Wall St. Rank held CME Group as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.